Bipartisan Bill Aims to Cap Insulin Costs at $35 Per Month

Got story updates? Submit your updates here. ›

A bipartisan group of senators has introduced a new bill that would cap the cost of insulin at $35 per month for people with diabetes. This move aims to provide relief for the high costs of the lifesaving drug, which can be a significant financial burden for many Americans who rely on it to manage their condition.

Why it matters

Insulin is a critical medication for people with diabetes, but its high cost has made it inaccessible for some patients. This bipartisan effort to lower insulin prices could improve access to this essential treatment and ease the financial strain on individuals and families dealing with the condition.

The details

The new bill would require health plans to cap the monthly cost of insulin at $35, regardless of the type or amount of insulin needed. This would apply to both private insurance plans and Medicare. The legislation is being championed by a group of senators from both parties, who are hoping to build on previous efforts to address the high price of insulin.

• The new bill was introduced in the U.S. Senate last week.
• If passed, the $35 per month insulin cap would go into effect immediately.

What they’re saying

What’s next

If passed, the bill would need to be signed into law by the President before the $35 per month insulin cap could take effect.